Abstract 3792: EGFR promotes immune evasion and resistance to immunotherapy in <i>NF1</i> mutant melanoma
Milad Ibrahim(New York University), Iman Osman(NYU Langone Health), Agrima Dutt(NYU Langone Health), Markus Schöber(Paracelsus Medical University), Tara Muijlwijk(NYU Langone Health), Ines Delclaux(NYU Langone Health), Katherine S. Ventre(NYU Langone Health), George Jour(NYU Langone Health), Shi Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Paola Angulo Salgado(NYU Langone Health), Amanda W. Lund(Eastern Cooperative Oncology Group), Irineu Illa-Bochaca(NYU Langone Health)
Cited by 0
Related Papers
Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
|Nature Genetics|2022|527
Lymphatic vessels regulate immune microenvironments in human and murine melanoma
|Journal of Clinical Investigation|2016|192
IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
|The Journal of Experimental Medicine|2018|161
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
|Cancer Cell|2021|154
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
|Nature Immunology|2023|113